Global Settlement for About 500 Androderm Cases by Actavis
Global Settlement for About 500 Androderm Cases by Actavis
Introduction
A case management order issued by Judge Matthew Kennelly on June 29, confirmed that Actavis has agreed to settle all Androderm lawsuits filed by men claiming they suffered a heart attack, stroke or other injuries as side effects of their testosterone replacement therapy (TRT) drug. As per the order, about 500 of the testosterone claims pending in the multidistrict litigation (MDL 2545; In Re: Testosterone Replacement Therapy Products Liability Litigation) involve Androderm.
Though no potential settlement order has been released, Judge Kennelly cited putting a stay on all Androderm claims against Actavis would allow parties to dedicate time and energy to finalize the agreement. The first bellwether trial date (August 6, 2018) for Androderm lawsuits has not been vacated yet.
Testosterone Replacement Therapy lawsuits are centralized before U.S. District Judge Matthew Kennelly in the Northern District of Illinois as a part of a federal multidistrict litigation (MDL No. 2545; In Re: Testosterone Replacement Therapy Products Liability Litigation).
Comments
Latest News
Supreme Court Upholds Flavored Vape Ban
Categories: E-Cigarette: JUUL
The U.S. Supreme Court has unanimously upheld a decision by the Food and Drug Administration (FDA) to block the sale and marketing of certain flavored e-cigarette products.
The ruling supports the FDA’s authority to regulate tobacco…
Judge Rejects JnJ's $10B Talc Lawsuit Settlement
Categories: Talcum
Johnson & Johnson's shares fell more than 5% after a U.S. bankruptcy judge rejected its $10 billion settlement proposal aimed at resolving over 60,000 lawsuits.
These lawsuits allege that the company’s…
Tepezza Hearing Loss MDL: Bellwether Trials Set for 2026
Categories: Tepezza
A U.S. District Judge overseeing Tepezza hearing damage lawsuits nationwide has scheduled four bellwether trials for 2026. These trials are intended to help both parties assess how juries may respond to the evidence and testimonies that could be…